Cart
sales@molnova.com
Phenylglyoxylic acid
CAS No. 611-73-4
Phenylglyoxylic acid( Benzoyl formate | Phenylglyoxalic acid | Phenylglyoxylate )
Catalog No. M21366 CAS No. 611-73-4
Phenylglyoxylic acid is a metabolite of ethylbenzene and styrene.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NamePhenylglyoxylic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenylglyoxylic acid is a metabolite of ethylbenzene and styrene.
-
DescriptionPhenylglyoxylic acid is a metabolite of ethylbenzene and styrene.
-
In Vitro——
-
In Vivo——
-
SynonymsBenzoyl formate | Phenylglyoxalic acid | Phenylglyoxylate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number611-73-4
-
Formula Weight150.13
-
Molecular FormulaC8H6O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:3 mg/mL (199.82 mM)
-
SMILESOC(C(c1ccccc1)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Capella K M Roland K Geldner N et al. Ethylbenzene and styrene exposure in the United States based on urinary mandelic acid and phenylglyoxylic acid: NHANES 2005-2006 and 2011-2012[J]. Environmental research 2019 171(APR.):101-110.
molnova catalog
related products
-
Fibronectin Adhesion...
Fibronectin Adhesion-promoting Peptide (Heparin Binding Peptide) is one of the heparin-binding amino acid sequences found in the carboxy-terminal heparin-binding domain of fibronectin. It promotes assembly of mesenchymal stem cell (MSC) spheroids into larger aggregates.
-
KM1954
N-(3,5-Bis(trifluoromethyl)phenyl)-2-chloroacetamide is an insecticide, it is most active against 1st stage Ae. aegypti larvae with LC50 values of 125μM.
-
TGFβRI-IN-3
TGFβRI-IN-3 is a highly selective TGFβR1 inhibitor with an IC50 of 0.79 nM and exhibits 2000-fold selectivity against MAP4K4, showing potential applications in immuno-oncology .
